Literature DB >> 16915022

Characteristics of resistant hypertension determined by self-measured blood pressure at home and office blood pressure measurements: the J-HOME study.

Takuya Oikawa1, Taku Obara, Takayoshi Ohkubo, Masahiro Kikuya, Kei Asayama, Hirohito Metoki, Rie Komai, Kayo Murai, Junichiro Hashimoto, Kazuhito Totsune, Yutaka Imai.   

Abstract

OBJECTIVES: To diagnose resistant hypertension using self-measured blood pressure (BP) at home and office BP, and to evaluate the characteristics of resistant hypertensive patients.
METHODS: The subjects were 528 hypertensive patients taking at least three or more different antihypertensive drugs. Subjects were classified into four groups (controlled hypertension, isolated office resistant hypertension, isolated home resistant hypertension and sustained resistant hypertension) on the basis of the cut-off values of home BP (135/85 mmHg) and office BP (140/90 mmHg). The relationship between each resistant hypertension group and various factors was analysed using univariate and multivariate analyses.
RESULTS: Of the 528 patients, 17.8% were classified with controlled hypertension, 16.1% with isolated office resistant hypertension, 23.5% with isolated home resistant hypertension and 42.6% with sustained resistant hypertension. The presence of hypercholesterolemia was found to have a significant and independent association with isolated office resistant hypertension. Higher office systolic blood pressure (SBP), a past history of ischaemic heart disease, and a lower prescription rate of potassium-sparing diuretics were found to have a significant and independent association with isolated home resistant hypertension. Patients with sustained resistant hypertension had a significantly lower prescription rate of potassium-sparing diuretics than those with controlled hypertension.
CONCLUSIONS: The present study demonstrated that resistant hypertension is mediated at least partly by the white-coat effect. Home BP measurements and other relevant factors associated with resistant hypertension, such as relatively higher office SBP, type of drugs prescribed, and cardiovascular complications, should be taken into account for the diagnosis and treatment of resistant hypertension.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16915022     DOI: 10.1097/01.hjh.0000242397.53214.27

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  9 in total

1.  Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association.

Authors:  Thomas G Pickering; Nancy Houston Miller; Gbenga Ogedegbe; Lawrence R Krakoff; Nancy T Artinian; David Goff
Journal:  Hypertension       Date:  2008-05-22       Impact factor: 10.190

2.  Managing white-coat effect.

Authors:  Joel Handler
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-08       Impact factor: 3.738

3.  Validation of Omron RS8, RS6, and RS3 home blood pressure monitoring devices, in accordance with the European Society of Hypertension International Protocol revision 2010.

Authors:  Hakuo Takahashi; Masamichi Yoshika; Toyohiko Yokoi
Journal:  Vasc Health Risk Manag       Date:  2013-05-28

4.  Cross-sectional study of the association between day-to-day home blood pressure variability and visceral fat area measured using the dual impedance method.

Authors:  Junko Kuwabara; Koichiro Kuwahara; Yoshihiro Kuwabara; Shinji Yasuno; Yasuaki Nakagawa; Kenji Ueshima; Takeshi Kimura
Journal:  PLoS One       Date:  2018-11-05       Impact factor: 3.240

Review 5.  Home and Office Blood Pressure Control among Treated Hypertensive Patients in Japan: Findings from the Japan Home versus Office Blood Pressure Measurement Evaluation (J-HOME) Study.

Authors:  Taku Obara; Takayoshi Ohkubo; Michihiro Satoh; Nariyasu Mano; Yutaka Imai
Journal:  Pharmaceuticals (Basel)       Date:  2010-02-04

6.  Home blood pressure data visualization for the management of hypertension: designing for patient and physician information needs.

Authors:  Richelle J Koopman; Shannon M Canfield; Jeffery L Belden; Pete Wegier; Victoria A Shaffer; K D Valentine; Akshay Jain; Linsey M Steege; Sonal J Patil; Mihail Popescu; Michael L LeFevre
Journal:  BMC Med Inform Decis Mak       Date:  2020-08-18       Impact factor: 2.796

7.  A Combination of Blood Pressure and Total Cholesterol Increases the Lifetime Risk of Coronary Heart Disease Mortality: EPOCH-JAPAN.

Authors:  Michihiro Satoh; Takayoshi Ohkubo; Kei Asayama; Yoshitaka Murakami; Daisuke Sugiyama; Takashi Waki; Sachiko Tanaka-Mizuno; Michiko Yamada; Shigeyuki Saitoh; Kiyomi Sakata; Fujiko Irie; Toshimi Sairenchi; Shizukiyo Ishikawa; Masahiko Kiyama; Akira Okayama; Katsuyuki Miura; Yutaka Imai; Hirotsugu Ueshima; Tomonori Okamura
Journal:  J Atheroscler Thromb       Date:  2020-04-08       Impact factor: 4.928

8.  A Japan nationwide web-based survey of estimation on patients for renal denervation based on blood pressure level and the number of antihypertensives (J-NEEDs survey).

Authors:  Hideaki Kagitani; Shoko Hayashi; Satsuki Hanamura; Keisuke Ozawa; Daisuke Kobayashi; Shunsuke Hiki; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-08-24       Impact factor: 3.738

9.  Call to action on use and reimbursement for home blood pressure monitoring: Executive Summary. A joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association.

Authors:  Thomas G Pickering; Nancy Houston Miller; Gbenga Ogedegbe; Lawrence R Krakoff; Nancy T Artinian; David Goff
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-06       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.